Innospec Inc. (IOSP) Financial Statements
Industry: Chemicals & Allied Products
In fiscal 2025, Innospec reported revenue of $1.78B, down 3.7% from $1.85B the year before. Net income was $116.6M (a 6.6% net margin), or $4.67 per diluted share. Gross margin was 27.7% and operating margin was 7.3%. Operating activities generated $138.3M of cash. At fiscal year end, Innospec held $1.83B in total assets against $499.5M in total liabilities, including $292.5M of cash and equivalents.
Open the full interactive Innospec financials → Quarterly statements, key ratios, valuation history and price charts.
Innospec Key Stats
| Share Price | $97.43 |
|---|---|
| Market Cap | $2.41B |
| P/E Ratio | 20.9 |
| Dividend Yield | 1.76% |
| Revenue YoY Growth | -3.6% |
| 52-Week Range | $65.12 – $98.72 |
| Shares Outstanding | 24.6 million (basic, 2026 Q2) |
Innospec Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.19B | $1.48B | $1.96B | $1.95B | $1.85B | $1.78B |
| Cost of Goods Sold | $850.4M | $1.05B | $1.38B | $1.36B | $1.30B | $1.29B |
| Gross Profit | $342.7M | $434.9M | $586.7M | $591.1M | $542.9M | $492.4M |
| Operating Income | $33.7M | $132.1M | $187.3M | $161.6M | $177.9M | $129.5M |
| Pre-Tax Income | $39.7M | $134.4M | $184.6M | $174.4M | $41.2M | $138.1M |
| Income Tax | $11.0M | $41.3M | $51.6M | $35.3M | $5.6M | $21.5M |
| Net Income | $28.6M | $93.0M | $133.0M | $139.0M | $33.2M | $116.6M |
| Diluted EPS | $1.16 | $3.75 | $5.32 | $5.56 | $1.42 | $4.67 |
Innospec Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $441.9M | $455.6M | $453.2M | $491.4M |
| Net Income | $12.7M | $46.4M | $30.4M | $30.8M |
| Diluted EPS | $0.52 | $1.86 | $1.22 | $1.25 |
Innospec Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $105.3M | $141.8M | $147.1M | $203.7M | $289.2M | $292.5M |
| Current Assets | $566.2M | $728.1M | $872.6M | $885.7M | $956.6M | $1.00B |
| Total Assets | $1.40B | $1.57B | $1.60B | $1.71B | $1.73B | $1.83B |
| Current Liabilities | $252.4M | $336.6M | $405.8M | $371.5M | $371.4M | $360.1M |
| Total Liabilities | $453.0M | $538.5M | $563.3M | $557.8M | $518.6M | $499.5M |
| Shareholders' Equity | $944.4M | $1.03B | $1.04B | $1.15B | $1.21B | $1.33B |
Innospec Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $145.9M | $93.2M | $81.7M | $207.3M | $184.5M | $138.3M |
| Cash From Investing | -$29.7M | -$36.2M | -$42.1M | -$111.8M | -$62.0M | -$75.1M |
| Cash From Financing | -$86.8M | -$20.0M | -$33.7M | -$39.0M | -$35.3M | -$63.9M |
| Dividends Paid | $25.6M | $28.8M | $31.7M | $35.1M | $38.8M | $42.4M |
Figures from Innospec's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Innospec financials page for every line item.
Innospec Company Profile
| Ticker | IOSP |
|---|---|
| Exchange | Nasdaq |
| Industry | Chemicals & Allied Products |
| Headquarters | Englewood, Colorado |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001054905 |
Frequently Asked Questions
What was Innospec's revenue in fiscal 2025?
Innospec (IOSP) reported revenue of $1.78B for fiscal 2025.
What is Innospec's annual revenue history?
Innospec's annual revenue by fiscal year: 2020: $1.19B; 2021: $1.48B; 2022: $1.96B; 2023: $1.95B; 2024: $1.85B; 2025: $1.78B.
What was Innospec's net income in fiscal 2025?
Innospec reported net income of $116.6M for fiscal 2025.
What was Innospec's earnings per share (EPS) in fiscal 2025?
Innospec's diluted EPS was $4.67 for fiscal 2025 (adjusted for any later stock splits).
What was Innospec's revenue last quarter?
In its most recent reported quarter (2026 Q2), Innospec reported revenue of $491.4M.
How many shares of Innospec are outstanding?
Innospec reported a weighted average of 24.6 million basic shares outstanding in 2026 Q2.
What is Innospec's market cap?
Based on its latest closing price, Innospec (IOSP) has a market capitalization of about $2.41B.
When does Innospec's fiscal year end?
Innospec's fiscal year end, as registered with the SEC, is December 31.
Where is Innospec headquartered?
Innospec lists its business address in Englewood, Colorado in its SEC filings.